Business: Clinical-stage biotech focused on treating bone diseases. Venator Materials - The Woodlands, Texas, 22.7 million shares, priced $20-$22, ...
News
- Initial public offerings scheduled to debut next week
- Baby Boomer Alert: Doctors Say Get A Hepatitis C Test
Bioscience-Medicine reporter Wendy Rigby has more. ... are infected," stated Barbara Turner, MD, physician researcher at UT Health San Antonio.
- Shkreli portrayed as con, prodigy at securities fraud trial
Former biotech CEO Martin Shkreli, center, leaves federal court with his attorney Benjamin Brafman, left, Thursday, July 27, 2017, in New York.
- The Latest: 'Pharma Bro' jury to begin deliberations Monday
Former biotech CEO Martin Shkreli, right, leaves federal court with a member of his legal team Thursday, July 27, 2017, in New York. Shkreli's defense ...
- Institute to develop transplant organs for injured vets
Officials say it will bring good jobs to Manchester and give the state's college graduates opportunities to work on cutting-edge biomedical research.